onr:"swepub:oai:DiVA.org:oru-98903"
Search: onr:"swepub:oai:DiVA.org:oru-98903" >
- 1 of
- Previous record
- To hitlist
The European response to control and manage multi- and extensively drug-resistant Neisseria gonorrhoeae
-
- Cole, Michelle J. (author)
- UK Health Security Agency, London, United Kingdom
-
- Day, Michaela (author)
- UK Health Security Agency, London, United Kingdom
-
- Jacobsson, Susanne, 1974- (author)
- Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,World Health Organization Collaborating Centre for Gonorrhoea and other STIs
- show more...
- European Gonorrhoea Response Plan Group, - (contributor)
- show less...
- (creator_code:org_t)
- European Centre for Disease Prevention and Control, 2022
- English.
- In: Eurosurveillance. - : European Centre for Disease Prevention and Control. - 1025-496X .- 1560-7917. ; 27:18, s. 37-43
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Because cefixime and ceftriaxone resistance in Neisseria gonorrhoeae and gonorrhoea treatment failures were increasing, a response plan to control and manage multidrug-resistant N. gonorrhoeae (MDR-NG) in Europe was published in 2012. The three main areas of the plan were to: (i) strengthen surveillance of antimicrobial resistance (AMR), (ii) implement monitoring of treatment failures and (iii) establish a communication strategy to increase awareness and disseminate AMR results. Since 2012, several additional extensively drug-resistant N. gonorrhoeae (XDR-NG) strains have emerged, and strains with high-level ceftriaxone resistance spread internationally. This prompted an evaluation and review of the 2012 European Centre for Disease Prevention and Control (ECDC) response plan, revealing an overall improvement in many aspects of monitoring AMR in N. gonorrhoeae; however, treatment failure monitoring was a weakness. Accordingly, the plan was updated in 2019 to further support European Union/European Economic Area (EU/EEA) countries in controlling and managing the threat of MDR/XDR-NG in Europe through further strengthening of AMR surveillance and clinical management including treatment failure monitoring. The plan will be assessed biennially to ensure its effectiveness and its value. Along with prevention, diagnostic, treatment and epidemiological surveillance strategies, AMR surveillance is essential for effective control of gonorrhoea.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Keyword
- EU/EEA
- MDR-NG
- XDR-NG
- antimicrobial resistance
- cephalosporins
- gonorrhoea
- surveillance
- treatment failure
Publication and Content Type
- ref (subject category)
- art (subject category)
To the university's database
- 1 of
- Previous record
- To hitlist
Find more in SwePub
- By the author/editor
- Cole, Michelle J ...
- Day, Michaela
- Jacobsson, Susan ...
- Amato-Gauci, And ...
- Spiteri, Gianfra ...
- Unemo, Magnus, 1 ...
- show more...
- European Gonorrh ...
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Infectious Medic ...
- Articles in the publication
- Eurosurveillance
- By the university
- Örebro University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
